Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Novartis Advertising Cited By FDA For Fifth Time In Less Than A Year

Feb 14 2011

• By The Pink Sheet Daily

Related Content

FDA Warns Novartis, Shire On Misbranding

May 09 2008

Novartis Inks Second Off-Label Settlement With DoJ, Paying $72.5 Million Over TOBI Marketing

May 05 2010

FDA Objects To Claims Based On Low-Quality Evidence In DTC Ads

Apr 26 2010

Watching Your Language: FDA Ad Division Objects To User-Friendly Efficacy Claims With Jargon-y Risk Info

Feb 08 2010

Exforge Money-back Guarantee Leaves DDMAC Complaining

Aug 06 2010

DDMAC Dislike: FDA Cracks Down On Facebook Widget Used On Tasigna Website

Aug 05 2010

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window